These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 32381174

  • 1. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
    Park H, Kam TI, Dawson TM, Dawson VL.
    Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
    [Abstract] [Full Text] [Related]

  • 2. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
    Liu L, Li J, Ke Y, Zeng X, Gao J, Ba X, Wang R.
    Cell Mol Life Sci; 2022 Jan 09; 79(1):60. PubMed ID: 35000037
    [Abstract] [Full Text] [Related]

  • 3. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
    Xu X, Sun B, Zhao C.
    Neurobiol Dis; 2023 Oct 15; 187():106314. PubMed ID: 37783233
    [Abstract] [Full Text] [Related]

  • 4. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
    Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, Poirier GG, Dawson VL, Dawson TM.
    Sci Signal; 2011 Apr 05; 4(167):ra20. PubMed ID: 21467298
    [Abstract] [Full Text] [Related]

  • 5. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
    Fatokun AA, Dawson VL, Dawson TM.
    Br J Pharmacol; 2014 Apr 05; 171(8):2000-16. PubMed ID: 24684389
    [Abstract] [Full Text] [Related]

  • 6. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.
    Wang Y, Dawson VL, Dawson TM.
    Exp Neurol; 2009 Aug 05; 218(2):193-202. PubMed ID: 19332058
    [Abstract] [Full Text] [Related]

  • 7. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.
    Yang L, Guttman L, Dawson VL, Dawson TM.
    Biochem Pharmacol; 2024 Oct 05; 228():116174. PubMed ID: 38552851
    [Abstract] [Full Text] [Related]

  • 8. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
    Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J.
    JCI Insight; 2019 Feb 21; 4(4):. PubMed ID: 30830864
    [Abstract] [Full Text] [Related]

  • 9. PARkinson's: From cellular mechanisms to potential therapeutics.
    Lengyel-Zhand Z, Puentes LN, Mach RH.
    Pharmacol Ther; 2022 Feb 21; 230():107968. PubMed ID: 34391789
    [Abstract] [Full Text] [Related]

  • 10. Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.
    Lee Y, Kang HC, Lee BD, Lee YI, Kim YP, Shin JH.
    BMB Rep; 2014 Aug 21; 47(8):424-32. PubMed ID: 24874851
    [Abstract] [Full Text] [Related]

  • 11. Cell Death Mechanisms of Neurodegeneration.
    Fan J, Dawson TM, Dawson VL.
    Adv Neurobiol; 2017 Aug 21; 15():403-425. PubMed ID: 28674991
    [Abstract] [Full Text] [Related]

  • 12. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
    Mashimo M, Onishi M, Uno A, Tanimichi A, Nobeyama A, Mori M, Yamada S, Negi S, Bu X, Kato J, Moss J, Sanada N, Kizu R, Fujii T.
    J Biol Chem; 2021 Aug 21; 296():100046. PubMed ID: 33168626
    [Abstract] [Full Text] [Related]

  • 13. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53.
    So KY, Oh SH.
    Biochem Biophys Res Commun; 2023 May 14; 656():78-85. PubMed ID: 36958258
    [Abstract] [Full Text] [Related]

  • 14. Poly(ADP-ribose) signaling in cell death.
    Virág L, Robaszkiewicz A, Rodriguez-Vargas JM, Oliver FJ.
    Mol Aspects Med; 2013 Dec 14; 34(6):1153-67. PubMed ID: 23416893
    [Abstract] [Full Text] [Related]

  • 15. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.
    Thapa K, Khan H, Sharma U, Grewal AK, Singh TG.
    Life Sci; 2021 Feb 15; 267():118975. PubMed ID: 33387580
    [Abstract] [Full Text] [Related]

  • 16. Ceramide induces macrophage migration inhibitory factor -mediated parthanatos in mouse neurons by increasing ROS levels.
    Fan C, Tian Y, Zhang Y, Teng J, Zhao X.
    Neurosci Lett; 2022 Sep 25; 788():136862. PubMed ID: 36075319
    [Abstract] [Full Text] [Related]

  • 17. Poly(ADP-ribosylation) and neurodegenerative disorders.
    Basello DA, Scovassi AI.
    Mitochondrion; 2015 Sep 25; 24():56-63. PubMed ID: 26196946
    [Abstract] [Full Text] [Related]

  • 18. ADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stress.
    Mashimo M, Kato J, Moss J.
    Proc Natl Acad Sci U S A; 2013 Nov 19; 110(47):18964-9. PubMed ID: 24191052
    [Abstract] [Full Text] [Related]

  • 19. Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons.
    Narne P, Pandey V, Simhadri PK, Phanithi PB.
    Semin Cell Dev Biol; 2017 Mar 19; 63():154-166. PubMed ID: 27867042
    [Abstract] [Full Text] [Related]

  • 20. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
    Liu C, Fang Y.
    Biochem Pharmacol; 2019 Sep 19; 167():58-63. PubMed ID: 31034795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.